ALX4
protein-codingALX homeobox 4, the group of PRD class homeoboxes and pseudogenes
Gene summary
This gene encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones, limbs, hair, teeth, and mammary tissue. Mutations in this gene cause parietal foramina 2 (PFM2); an autosomal dominant disease characterized by deficient ossification of the parietal bones. Mutations in this gene also cause a form of frontonasal dysplasia with alopecia and hypogonadism; suggesting a role for this gene in craniofacial development, mesenchymal-epithelial communication, and hair follicle development. Deletion of a segment of chromosome 11 containing this gene, del(11)(p11p12), causes Potocki-Shaffer syndrome (PSS); a syndrome characterized by craniofacial anomalies, cognitive disability, multiple exostoses, and genital abnormalities in males. In mouse, this gene has been shown to use dual translation initiation sites located 16 codons apart. [provided by RefSeq, Oct 2009]
- PFM2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~49.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0012309
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: ClinGen
ALX4 has been repeatedly described in association with autosomal recessive frontonasal dysplasia with alopecia and genital anomaly. Frontonasal dysplasia 1 is characterized by having a distinctive facial appearance with hypertelorism, broad nasal bridge, short nasal ridge, splayed nasal bones with bifid nasal tip, broad columella that attaches to the lip above the alae, widely separated slit-like nares, long philtrum with prominent bilateral swellings, and midline notch in the upper lip and alveolus. At least 1 missense, 2 nonsense, 1 splice acceptor, and 1 deletion mutations have been reported in at least 5 probands from 4 publications (PMIDs: 19409524, 22106187, 29215096, 34098755) This gene disease association is also supported by experimental evidence including expression data and an animal model (PMID: 20534379). In summary, ALX4 is definitively associated with autosomal recessive Frontonasal dysplasia 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.
Inheritance Pattern: AD
Disease ID:MONDO:0012309
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0018953
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014232
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0012309
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0012309
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013268
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Variants may contribute to nonsyndromic craniosynostosis
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ALX4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021926.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 32 | 3 | 42 | ||
| missense | 4 | 1 | 103 | 10 | 2 | 120 |
| nonsense | 5 | 2 | 1 | 8 | ||
| start loss | 1 | 1 | ||||
| frameshift | 6 | 11 | 1 | 18 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 15 | 14 | 113 | 42 | 5 | 189 |
Highest pathogenic variant AF is 0.000014532329
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068745.2 | 4 | MANE Select | |
| Ensembl | ENSP00000498217.1 | 4 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- skeletal system development
- hair follicle development
- muscle organ development
- post-embryonic development
- anterior/posterior pattern specification
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA binding
- protein heterodimerization activity
Cellular Component
- nucleus
- transcription factor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000329255
- Coding exons
- 4
- Length
- 49723
- Individuals with no LoFs
- 125735
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 13
- Defined
- 125748
- p
- 0.0000517
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.821 | 213 | 249 | 0.854 | 0.0000147 | 2615 |
| Missense (PolyPhen) | 84 | 104.53 | 0.80357 | 1030 | ||
| Synonymous | -1.53 | 128 | 108 | 1.19 | 0.00000653 | 812 |
| Loss of Function | 3.01 | 4 | 17.6 | 0.227 | 9.99e-7 | 163 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00025 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000042 | 0.000035 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00035 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor involved in skull and limb development. Plays an essential role in craniofacial development, skin and hair follicle development. {ECO:0000269|PubMed:19692347}.;
- Disease
- DISEASE: Frontonasal dysplasia 2 (FND2) [MIM:613451]: The term frontonasal dysplasia describes an array of abnormalities affecting the eyes, forehead and nose and linked to midfacial dysraphia. The clinical picture is highly variable. Major findings include true ocular hypertelorism; broadening of the nasal root; median facial cleft affecting the nose and/or upper lip and palate; unilateral or bilateral clefting of the alae nasi; lack of formation of the nasal tip; anterior cranium bifidum occultum; a V-shaped or widow's peak frontal hairline. {ECO:0000269|PubMed:19692347}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Potocki-Shaffer syndrome (POSHS) [MIM:601224]: A syndrome characterized by foramina parietalia permagna, multiple exostoses, and craniofacial dysostosis and mental retardation in some cases. {ECO:0000305|PubMed:11017806, ECO:0000305|PubMed:11903336}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Craniosynostosis 5 (CRS5) [MIM:615529]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:22829454}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.216
Intolerance Scores
- LoFtool
- 0.155
- RVIS EVS
- -0.45
- RVIS percentile EVS
- 24.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.946
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |